<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News</title>
	<atom:link href="https://oralcancernews.org/wp/feed/" rel="self" type="application/rss+xml" />
	<link>https://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Wed, 01 Apr 2026 20:52:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>In Memoriam: Brian Hill</title>
		<link>https://oralcancernews.org/wp/in-memoriam-brian-hill/</link>
					<comments>https://oralcancernews.org/wp/in-memoriam-brian-hill/#respond</comments>
		
		<dc:creator><![CDATA[Webmaster]]></dc:creator>
		<pubDate>Wed, 01 Apr 2026 20:48:04 +0000</pubDate>
				<category><![CDATA[OCF In The News]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22092</guid>

					<description><![CDATA[The Oral Cancer Foundation mourns the passing of Brian Hill, our co-founder and a tireless advocate for patients, survivors, and families affected by oral cancer. Together with his late wife, Ingrid Hill, Brian helped establish the Oral Cancer Foundation, whose vision is rooted in compassion, education, advocacy, and support. What began as a deeply  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/in-memoriam-brian-hill/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>An urgent argument for the HPV vaccine</title>
		<link>https://oralcancernews.org/wp/an-urgent-argument-for-the-hpv-vaccine/</link>
					<comments>https://oralcancernews.org/wp/an-urgent-argument-for-the-hpv-vaccine/#respond</comments>
		
		<dc:creator><![CDATA[Webmaster]]></dc:creator>
		<pubDate>Thu, 13 Mar 2025 02:06:18 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22084</guid>

					<description><![CDATA[Source: NPR  Chris Riley's symptoms started in the summer of 2021. At first, he didn't think much about them. His throat felt a little sore, and he noticed hardening of his lymph nodes. At 57 years old, Riley was active and healthy. He biked everywhere and didn't even own a car. Riley, it turned out,  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/an-urgent-argument-for-the-hpv-vaccine/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>The widespread application of trans-oral robotic surgery in HPV-related head and neck cancer: one size does not fit all</title>
		<link>https://oralcancernews.org/wp/the-widespread-application-of-trans-oral-robotic-surgery-in-hpv-related-head-and-neck-cancer-one-size-does-not-fit-all/</link>
					<comments>https://oralcancernews.org/wp/the-widespread-application-of-trans-oral-robotic-surgery-in-hpv-related-head-and-neck-cancer-one-size-does-not-fit-all/#respond</comments>
		
		<dc:creator><![CDATA[OCF News Team - B]]></dc:creator>
		<pubDate>Mon, 23 Dec 2024 17:57:22 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cancer management]]></category>
		<category><![CDATA[oral cancer surgery]]></category>
		<category><![CDATA[Trans-Oral Robotic Surgery]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22077</guid>

					<description><![CDATA[Over the past years, trans-oral robotic surgery (TORS) has gained momentum and wide applicability in the treatment of early-stage low-risk HPV-related oropharyngeal squamous cell carcinoma (OPSCC). This is in large part due to initial large single-institution series documenting good clinical outcomes using this approach. This culminated in the design and execution of the Eastern Cooperative Oncology  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/the-widespread-application-of-trans-oral-robotic-surgery-in-hpv-related-head-and-neck-cancer-one-size-does-not-fit-all/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Exploring the link between HPV infection and head and neck cancers</title>
		<link>https://oralcancernews.org/wp/exploring-the-link-between-hpv-infection-and-head-and-neck-cancers/</link>
					<comments>https://oralcancernews.org/wp/exploring-the-link-between-hpv-infection-and-head-and-neck-cancers/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Fri, 26 Apr 2024 21:00:35 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22066</guid>

					<description><![CDATA[Source: www.targetedonc.com Author: Jordyn Sava In an interview with Targeted Oncology for Head and Neck Cancer Awareness Month, Noel Laudi, MD, MRCP, discussed the link between human papillomavirus infection and head and neck cancers. There is a complex relationship that exists between human papillomavirus (HPV) and head and neck cancers. According to Noel Laudi, MD,  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/exploring-the-link-between-hpv-infection-and-head-and-neck-cancers/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Head and neck cancer surgeons test fluorescent dye for marking nerves</title>
		<link>https://oralcancernews.org/wp/head-and-neck-cancer-surgeons-test-fluorescent-dye-for-marking-nerves/</link>
					<comments>https://oralcancernews.org/wp/head-and-neck-cancer-surgeons-test-fluorescent-dye-for-marking-nerves/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Wed, 24 Apr 2024 13:08:17 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[dye]]></category>
		<category><![CDATA[electromyography]]></category>
		<category><![CDATA[fluorescence]]></category>
		<category><![CDATA[fluorescing]]></category>
		<category><![CDATA[nerves]]></category>
		<category><![CDATA[precision]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22061</guid>

					<description><![CDATA[Source: web.musc.edu Author: Leslie Cantu  Alexandra Kejner, M.D., right, operates using the Alume Biosciences nerve visualization dye. Photo provided  Head and neck cancer surgeons at MUSC Hollings Cancer Center are excited about the possibilities of a new nerve fluorescing product they’re testing in a phase III clinical trial. Developed by Alume Biosciences, the  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/head-and-neck-cancer-surgeons-test-fluorescent-dye-for-marking-nerves/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Researchers discover urine-based test to detect head and neck cancer</title>
		<link>https://oralcancernews.org/wp/researchers-discover-urine-based-test-to-detect-head-and-neck-cancer/</link>
					<comments>https://oralcancernews.org/wp/researchers-discover-urine-based-test-to-detect-head-and-neck-cancer/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Wed, 17 Apr 2024 12:52:41 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[circulating tumor DNA]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[genome]]></category>
		<category><![CDATA[urine]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22058</guid>

					<description><![CDATA[Source: www.newswise.com Author: Michigan Medicine - University of Michigan Researchers from the University of Michigan Health Rogel Cancer Center have created a urine-based test that detects pieces of DNA fragments released by head and neck tumors. The test could potentially facilitate early detection of this cancer type, which currently does not have a reliable screening  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/researchers-discover-urine-based-test-to-detect-head-and-neck-cancer/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Insilico Medicine&#8217;s AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy</title>
		<link>https://oralcancernews.org/wp/insilico-medicines-ai-driven-approach-yields-promising-ptpn2-n1-inhibitor-for-cancer-immunotherapy/</link>
					<comments>https://oralcancernews.org/wp/insilico-medicines-ai-driven-approach-yields-promising-ptpn2-n1-inhibitor-for-cancer-immunotherapy/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Mon, 15 Apr 2024 14:40:06 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22052</guid>

					<description><![CDATA[Source: www.news-medical.ne Author: InSilico Medicine staff In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances. But while immunotherapy drugs offer new treatment possibilities, only about 20% to 40% of patients respond to these treatments. The majority either don't respond or develop drug resistance. Researchers are now looking  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/insilico-medicines-ai-driven-approach-yields-promising-ptpn2-n1-inhibitor-for-cancer-immunotherapy/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>The growing role for cfHPV-DNA testing in OPSCC therapeutic development</title>
		<link>https://oralcancernews.org/wp/the-growing-role-for-cfhpv-dna-testing-in-opscc-therapeutic-development/</link>
					<comments>https://oralcancernews.org/wp/the-growing-role-for-cfhpv-dna-testing-in-opscc-therapeutic-development/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Mon, 15 Apr 2024 14:30:24 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[cfHPV-DNA]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[human papaloma virus]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22049</guid>

					<description><![CDATA[Source: www.biopharmadive.com Author: Sysmex Inostics,sponsored content Human papillomavirus (HPV) plays a key role in the development of oropharyngeal squamous cell carcinoma (OPSCC). Approximately 80% of all OPSCC cases in the U.S. are associated with HPV.1 In fact, the incidence of HPV-associated OPSCC in men has surpassed that of cervical cancer in women, making OPSCC the  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/the-growing-role-for-cfhpv-dna-testing-in-opscc-therapeutic-development/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>‘Paradoxical’ data show routine imaging lacks benefit for head and neck cancer survivors</title>
		<link>https://oralcancernews.org/wp/paradoxical-data-show-routine-imaging-lacks-benefit-for-head-and-neck-cancer-survivors/</link>
					<comments>https://oralcancernews.org/wp/paradoxical-data-show-routine-imaging-lacks-benefit-for-head-and-neck-cancer-survivors/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Thu, 14 Mar 2024 23:33:37 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[CT]]></category>
		<category><![CDATA[expectant]]></category>
		<category><![CDATA[imaging]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[MRI]]></category>
		<category><![CDATA[PET with CT]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[surveillance]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22041</guid>

					<description><![CDATA[Source: www.healio.com Author: Matthew Shinkle Key takeaways: Researchers saw no statistical difference between patient groups with respect to treatment outcomes. Larger studies are needed to further evaluate this study’s findings. Compared with expectant management, imaging-based surveillance did not improve outcomes among patients in remission after completion of primary radiation therapy for head and neck cancer,  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/paradoxical-data-show-routine-imaging-lacks-benefit-for-head-and-neck-cancer-survivors/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>CERN detector could help treat brain tumors with greater precision</title>
		<link>https://oralcancernews.org/wp/cern-detector-could-help-treat-brain-tumors-with-greater-precision/</link>
					<comments>https://oralcancernews.org/wp/cern-detector-could-help-treat-brain-tumors-with-greater-precision/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Sun, 10 Mar 2024 16:47:56 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[ion radiotherapy]]></category>
		<category><![CDATA[pixel detector]]></category>
		<category><![CDATA[Timepix3]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22037</guid>

					<description><![CDATA[Source: www.inceptivemind.com Author: Ashwini Sakharkar  Mária Martišíková (left), the project leader from Heidelberg University Hospital and German Cancer Research Center (DKFZ), and DKFZ researcher Laurent Kelleter. Credit: Heidelberg University Hospital / H.Schroeder  Scientists are testing a new device that will help them more accurately target cancer cells during ion radiotherapy for head and  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/cern-detector-could-help-treat-brain-tumors-with-greater-precision/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Rhod Gilbert: Doctor reveals how &#8216;brutal&#8217; therapy tackled comedian&#8217;s cancer</title>
		<link>https://oralcancernews.org/wp/rhod-gilbert-doctor-reveals-how-brutal-therapy-tackled-comedians-cancer/</link>
					<comments>https://oralcancernews.org/wp/rhod-gilbert-doctor-reveals-how-brutal-therapy-tackled-comedians-cancer/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Sun, 10 Mar 2024 16:38:28 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[dry mouth]]></category>
		<category><![CDATA[fatigue]]></category>
		<category><![CDATA[lack of taste]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[ulcers]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22030</guid>

					<description><![CDATA[Source: www.bbc.com Author: Natalie Grice, BBC News  Prof Mererid Evans says Rhod Gilbert "wanted something positive to come out of his experience"  "A patient once described it to me as brutal, and it's really stuck with me, because it's difficult to go through." What's so brutal? It's the cancer treatment Prof Mererid Evans  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/rhod-gilbert-doctor-reveals-how-brutal-therapy-tackled-comedians-cancer/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>A case for radiation enhancement in head and neck cancer</title>
		<link>https://oralcancernews.org/wp/a-case-for-radiation-enhancement-in-head-and-neck-cancer/</link>
					<comments>https://oralcancernews.org/wp/a-case-for-radiation-enhancement-in-head-and-neck-cancer/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Fri, 08 Mar 2024 17:05:03 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[hafnium oxide]]></category>
		<category><![CDATA[nanoparticles]]></category>
		<category><![CDATA[radioenhancers]]></category>
		<category><![CDATA[vismodegib]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22027</guid>

					<description><![CDATA[Source: www.medscape.com Author: M. Alexander Otto, PA, MMS Two new exploratory studies of radioenhancers used in combination with radiation therapy in the treatment of head and neck cancers showed that these agents can boost the effectiveness of radiotherapy in these cancers. The two phase 2 studies, presented at the 2024 American Society for Radiation Oncology  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/a-case-for-radiation-enhancement-in-head-and-neck-cancer/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Prognostic factors linked with poor locoregional control in tongue cancer</title>
		<link>https://oralcancernews.org/wp/prognostic-factors-linked-with-poor-locoregional-control-in-tongue-cancer/</link>
					<comments>https://oralcancernews.org/wp/prognostic-factors-linked-with-poor-locoregional-control-in-tongue-cancer/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Thu, 07 Mar 2024 03:42:18 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[adjuvant radiotherapy]]></category>
		<category><![CDATA[locoregional control]]></category>
		<category><![CDATA[margins]]></category>
		<category><![CDATA[neck dissection]]></category>
		<category><![CDATA[partial glossectomy]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22024</guid>

					<description><![CDATA[Source: www.cancernetwork.com Author: Gina Mauro Depth of invasion, lymphovascular space invasion, and positive glossectomy specimen margins were all found to be linked with inferior locoregional control (LRC) in patients with pT1-2N0 oral tongue squamous cell carcinoma who were treated with partial glossectomy and elective neck dissection alone. The retrospective findings, which were presented during the  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/prognostic-factors-linked-with-poor-locoregional-control-in-tongue-cancer/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Novel therapy promising for radiation-induced oral mucositis</title>
		<link>https://oralcancernews.org/wp/novel-therapy-promising-for-radiation-induced-oral-mucositis/</link>
					<comments>https://oralcancernews.org/wp/novel-therapy-promising-for-radiation-induced-oral-mucositis/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Wed, 06 Mar 2024 19:06:26 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[mucositis]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[Uridine]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22022</guid>

					<description><![CDATA[Source: www.medpagetoday.com Author: Mike Bassett, Staff Writer, MedPage Today The first-in-class uridine phosphorylase inhibitor TK-90 almost completely eliminated severe oral mucositis (SOM) in patients with non-metastatic squamous cell carcinoma of the head and neck who underwent radiation therapy, a small randomized study showed. None of the 12 patients treated with TK-90 developed SOM by the  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/novel-therapy-promising-for-radiation-induced-oral-mucositis/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Case Western Reserve University-led research team discovers new method to test for oral cancer</title>
		<link>https://oralcancernews.org/wp/case-western-reserve-university-led-research-team-discovers-new-method-to-test-for-oral-cancer/</link>
					<comments>https://oralcancernews.org/wp/case-western-reserve-university-led-research-team-discovers-new-method-to-test-for-oral-cancer/#respond</comments>
		
		<dc:creator><![CDATA[Oral Cancer Foundation News Team - A]]></dc:creator>
		<pubDate>Tue, 05 Mar 2024 19:10:27 +0000</pubDate>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[beta defensin index]]></category>
		<category><![CDATA[biopsies]]></category>
		<category><![CDATA[hBD-2]]></category>
		<category><![CDATA[hBD-3]]></category>
		<category><![CDATA[lesions]]></category>
		<category><![CDATA[POC]]></category>
		<category><![CDATA[point-of-care]]></category>
		<guid isPermaLink="false">https://oralcancernews.org/wp/?p=22018</guid>

					<description><![CDATA[Source: thedaily.case.edu Author: staff Oral cancers and precancerous mouth lesions are considered especially difficult to diagnose early and accurately. For one, biopsies are expensive, invasive, stressful for the patient and can lead to complications. They’re also not feasible if repeated screenings of the same lesion are required. But a team of researchers, led by a  [...]]]></description>
		
					<wfw:commentRss>https://oralcancernews.org/wp/case-western-reserve-university-led-research-team-discovers-new-method-to-test-for-oral-cancer/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
